Sperm doesn’t directly cause preeclampsia, but exposure to a specific partner’s semen before conception plays a surprising role in whether the condition develops. The connection comes down to your immune system: seminal fluid contains proteins unique to the father, and your body needs time to build tolerance to those proteins before pregnancy. When that tolerance is insufficient, the risk of preeclampsia rises.
How Semen Primes Your Immune System
Pregnancy is, immunologically speaking, similar to an organ transplant. Half the genetic material in your developing baby comes from the father, which means the placenta carries foreign proteins your immune system would normally attack. For a healthy pregnancy, your body has to learn to tolerate those specific proteins rather than mount an immune response against them.
That learning process starts well before conception. Seminal fluid is one of the richest biological sources of a signaling molecule called TGF-beta, a potent driver of immune tolerance. When semen is deposited in the reproductive tract, the acidic vaginal environment activates TGF-beta, triggering a controlled inflammatory response. This response recruits immune cells to the uterine lining, where they encounter the father’s unique cellular markers carried in the seminal plasma.
Over repeated exposures, this process expands a population of specialized immune cells called regulatory T cells. In mouse studies, mating with intact males increased the number of these tolerance-promoting cells by 2.7-fold in the lymph nodes draining the uterus within just a few days. These regulatory T cells essentially teach the rest of your immune system to accept the father’s genetic markers, both in the semen itself and later in the placenta, since many of the same markers appear on both.
Why a New Partner Raises the Risk
Some of the strongest evidence for sperm’s role in preeclampsia comes from studies on partner changes. When a woman has a second pregnancy with a new partner, her preeclampsia risk jumps significantly because her immune system hasn’t been primed to that man’s specific proteins. One study found preeclampsia rates of 4% among women having a second pregnancy with the same partner, compared to 24% among women with a new partner. For context, the rate among first-time mothers was 11.9%.
The reverse is also telling. Women who had preeclampsia in a first pregnancy actually see their risk decrease if they change partners for their next pregnancy, likely because the immunological mismatch was specific to the first pairing. Meanwhile, if a man previously fathered a pregnancy complicated by preeclampsia, his next partner faces a higher risk too. The baseline increase from changing partners is about 1.6%, but it climbs to 2.9% when the new partner has that history. This points to something about the father’s biology, not just the mother’s, contributing to the condition.
Duration of Sexual Contact Matters
If immune tolerance builds over repeated semen exposure, then the length of time a couple has unprotected sex before conception should matter. It does. Women who conceived within three months or less of their first sexual contact with a partner had more than double the odds of developing preeclampsia compared to those with longer sexual relationships (adjusted odds ratio of 2.32). Women who conceived after their very first intercourse with a partner had nearly six times the odds (adjusted odds ratio of 5.75), though that group was small.
Even at the six-month mark, the risk remained elevated, with women in relationships of six months or shorter showing roughly 1.9 times the odds of preeclampsia. The pattern is consistent: more time exposed to a partner’s seminal fluid before pregnancy means a better-trained immune system and lower preeclampsia risk.
Donor Eggs and the Immune Mismatch
Pregnancies from donated eggs provide another window into this immune mechanism. In donor egg pregnancies, the embryo carries entirely foreign genetic material from both the egg donor and the sperm provider, meaning the mother’s immune system has had no prior exposure to the egg donor’s proteins at all. The result is striking: preeclampsia occurs in about 17.2% of donor egg pregnancies, compared to 5.7% of standard IVF pregnancies using the mother’s own eggs. That’s roughly a threefold increase in risk.
This finding reinforces the idea that immune familiarity with the baby’s genetic profile is protective. When semen exposure has had time to build tolerance to the father’s contribution, at least half the equation is covered. But when neither parent’s genetic markers are familiar, as with donor eggs, the risk climbs substantially.
What About Barrier Contraception?
If semen exposure builds protection, you might expect that couples who used condoms before conception would face higher preeclampsia rates. Researchers tested this directly, and the answer was no. Two studies found no significant association between barrier contraceptive use and preeclampsia risk. The odds ratios hovered around 0.85 to 0.91, meaning condom users had roughly the same rates as everyone else.
This doesn’t necessarily disprove the immune tolerance theory. It may simply mean that even limited or intermittent semen exposure is enough to begin the priming process, or that the duration of the overall relationship (and any unprotected contact within it) matters more than consistent barrier use. The contraception data is a reminder that the relationship between semen exposure and preeclampsia is more nuanced than a simple dose-response.
Oral Exposure and Tolerance
One widely discussed study found a correlation between oral sex involving swallowing semen and a lower incidence of preeclampsia. The proposed explanation draws on transplant immunology: oral exposure to foreign proteins is a well-established route for inducing immune tolerance. Researchers detected soluble versions of the father’s immune markers in seminal plasma and hypothesized that absorbing these through the digestive tract could help the mother’s immune system accept those same markers during pregnancy.
Preliminary data from that study also found lower levels of these soluble markers in the semen of men whose partners developed preeclampsia, though the difference wasn’t statistically significant. This is a single study with a small sample, so it’s best understood as an intriguing piece of a larger puzzle rather than actionable advice.
What This Means in Practice
Current clinical guidelines for preeclampsia screening don’t include questions about sexual history or partner changes. The standard risk factors your provider will assess are things like first pregnancy, obesity, a personal or family history of preeclampsia, and conditions like chronic high blood pressure or diabetes. The paternal immune connection, while well-supported in research, hasn’t yet been translated into clinical screening tools or prevention strategies.
What the research does offer is context. If you’re pregnant with a new partner, conceived quickly into a new relationship, or used donor eggs or donor sperm, the immune tolerance theory helps explain why your provider may monitor you more closely for preeclampsia. It also reframes preeclampsia as something shaped by the biological relationship between both parents, not solely a condition of the mother’s body.